Quantcast
Last updated on April 18, 2014 at 13:38 EDT

Latest ICU Medical Inc. Stories

2013-01-17 08:26:28

SAN CLEMENTE, Calif., Jan.17, 2013 /PRNewswire/ -- ICU Medical, Inc. (Nasdaq: ICUI) today announced it will launch the CardioFlo hemodynamic monitoring sensor system at the Society of Critical Care Medicine (SCCM) Critical Care Congress in San Juan, Puerto Rico, January 19-23, 2013. CardioFlo is a minimally invasive hemodynamic monitoring sensor system that, when used with an existing arterial catheter and connected to an Edwards Lifesciences Vigileo(®) monitor, provides accurate and...

2012-11-29 08:29:14

SAN CLEMENTE, Calif., Nov. 29, 2012 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced the U.S. launch of the Diana Hazardous Drug Compounding System at the American Society of Health System Pharmacists (ASHP) Midyear Meeting and Exposition in Las Vegas December 2-6, 2012. The Diana system is the world's first user-controlled automated sterile compounding system for the accurate, safe, and efficient preparation of hazardous drugs, and has been in clinical use in Europe for more...

2012-10-22 07:29:16

SAN CLEMENTE, Calif., Oct. 22, 2012 /PRNewswire/ -- A recent high-profile incident involving drug contamination and patient deaths associated with a compounding pharmacy underscores the safety challenges associated with current drug compounding processes throughout the country. Fortunately, there is a system available today that may help ensure the sterility of drugs during the drug compounding process. The Diana(TM) Hazardous Drug Compounding System, manufactured by ICU Medical, Inc....

2012-10-15 07:28:55

SAN CLEMENTE, Calif., Oct. 15, 2012 /PRNewswire/ -- ICU Medical, Inc. (Nasdaq:ICUI) today announced the introduction of the NanoClave low-profile neutral displacement needlefree connector, designed to keep neonatal and pediatric patients safe by minimizing flush volumes while providing a safe and effective microbial barrier. NanoClave will be debuted at the Association for Vascular Access (AVA) Annual Scientific Meeting in San Antonio, TX on October 16, 2012, the National Association of...

2012-09-06 02:31:48

SAN CLEMENTE, Calif., Sept. 6, 2012 /PRNewswire/ -- ICU Medical, Inc. (Nasdaq:ICUI) today announced they will be hosting a presentation by Seth Eisenberg, RN, OCN(®), titled "Nurse Safety with Hazardous Drugs: Where Do You Stand?" to educate nurses about the dangers of exposure to hazardous drugs and examine methods for exposure prevention. This presentation to attendees of the International Conference on Cancer Nursing (ICCN) will be held at the Hilton Prague Hotel, Prague, CZ, September...

2012-06-26 02:27:48

SAN CLEMENTE, Cali, June 26, 2012 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced that it has signed a contract with ROi (Resource Optimization & Innovation) for MicroClave® Clear neutral displacement needlefree IV connectors to be used on central and peripheral IV lines at Mercy, the eighth largest Catholic health care system in the United States, serving more than 3 million people annually. ROi is the health care supply chain company founded by Mercy more than a...

2012-06-13 02:27:20

SAN CLEMENTE, Calif., June 13, 2012 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) announced today that a clinical case study prepared by clinicians from Women & Infants Hospital in Providence, R.I. showed that a collaboratively-developed custom IV system featuring the MicroClave® needlefree neutral displacement connector helped reduce NICU infection rates and medication errors, while also addressing recent FDA concerns regarding the safety of positive displacement needlefree...

2012-06-07 10:23:59

SAN CLEMENTE, Calif. and ST. LOUIS, June 7, 2012 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) and Mobius Therapeutics, LLC today jointly announced that ICU Medical's ChemoClave(TM) system for the safe handling of hazardous drugs will be packaged with Mobius Therapeutics' Mitosol® kit, an FDA-cleared drug used in ophthalmic surgery containing the active ingredient Mitomycin-C, which is cytotoxic and listed on NIOSH Hazardous Drug List. By incorporating ChemoClave components into the...

2012-05-14 02:27:33

SAN CLEMENTE, Calif., May 14, 2012 /PRNewswire/ -- ICU Medical, (NASDAQ:ICUI) today announced that it would "vigorously seek to collect damages" as a result of its patent infringement victory over RyMed. ICU Medical filed a lawsuit in 2007 to stop RyMed Technologies from selling its patent-infringing In-Vision Plus needlefree connector. And, although RyMed modified its device, the company still pursued the infringement claims against both the original and current devices. On December 17,...

2012-05-03 02:32:03

NEW ORLEANS, May 3, 2012 /PRNewswire-FirstCall/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced that two studies presented this week at the 37th Annual Congress of the Oncology Nursing Society (ONS) in New Orleans show that the company's ChemoClave(TM) needlefree closed system transfer device (CSTD) protects nurses from accidental exposure to hazardous chemotherapy drugs while increasing nurse satisfaction and perceptions of safety. The ChemoClave system is the world's...